Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101) von Gaillard, Pieter J, Appeldoorn, Chantal C M, Dorland, Rick, van Kregten, Joan, Manca, Francesca, Vugts, Danielle J, Windhorst, Bert, van Dongen, Guus A M S, de Vries, Helga E, Maussang, David, van Tellingen, Olaf

Volltext

PET‐CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients von Miedema, Iris H. C., Zwezerijnen, Gerben J. C., Huisman, Marc C., Doeleman, Ellen, Mathijssen, Ron H. J., Lammers, Twan, Hu, Qizhi, Dongen, Guus A. M. S., Rijcken, Cristianne J. F., Vugts, Danielle J., Menke‐van der Houven van Oordt, C. Willemien

Volltext

Investigation of the Impact of the H310A FcRn Region Mutation on 89Zr-Immuno-PET Brain Imaging with a BBB-Shuttle Anti‑Amyloid Beta Antibody von Wuensche, Thomas E., Stergiou, Natascha, Mes, Iris, Verlaan, Mariska, Kooijman, Esther J. M., Windhorst, Albert D., Jensen, Allan, Asuni, Ayodeji A., Bang-Andersen, Benny, van Dongen, Guus A. M. S., Vugts, Danielle J., Beaino, Wissam

Volltext

The novel AML stem cell–associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells von van Rhenen, Anna, van Dongen, Guus A.M.S., Kelder, Angèle, Rombouts, Elwin J., Feller, Nicole, Moshaver, Bijan, Walsum, Marijke Stigter-van, Zweegman, Sonja, Ossenkoppele, Gert J., Jan Schuurhuis, Gerrit

Volltext

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET von Chomet, Marion, van Dongen, Guus A. M. S, Vugts, Danielle J

Volltext

An Efficient Conjugation Approach for Coupling Drugs to Native Antibodies via the PtII Linker Lx for Improved Manufacturability of Antibody–Drug Conjugates von Merkul, Eugen, Muns, Joey A., Sijbrandi, Niels J., Houthoff, Hendrik‐Jan, Nijmeijer, Bart, Rheenen, Gerro, Reedijk, Jan, Dongen, Guus A. M. S.

Volltext

Improving Routine 89Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO von Wuensche, Thomas E., Nauta, Sabine, Dongen, Guus A. M. S., Vugts, Danielle J.

Volltext

Preclinical evaluation and validation of [18F]HX4, a promising hypoxia marker for PET imaging von Dubois, Ludwig J, Lieuwes, Natasja G, Janssen, Marco H. M, Peeters, Wenny J. M, Windhorst, Albert D, Walsh, Joseph C, Kolb, Hartmuth C, Öllers, Michel C, Bussink, Johan, van Dongen, Guus A. M. S, van der Kogel, Albert, Lambin, Philippe

Volltext

Good practices for 89Zr radiopharmaceutical production and quality control von Wuensche, Thomas Erik, Lyashchenko, Serge, van Dongen, Guus A. M. S., Vugts, Danielle

Volltext

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor von Högnäsbacka, Antonia, Poot, Alex J, Vugts, Danielle J, van Dongen, Guus A M S, Windhorst, Albert D

Volltext

Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor von Högnäsbacka, Antonia A., Poot, Alex J., Plisson, Christophe, Bergare, Jonas, Bonsall, David R., McCluskey, Stuart P., Wells, Lisa A., Kooijman, Esther, Schuit, Robert C., Verlaan, Mariska, Beaino, Wissam, van Dongen, Guus A. M. S., Vugts, Danielle J., Elmore, Charles S., Passchier, Jan, Windhorst, Albert D.

Volltext

Non-specific irreversible 89Zr-mAb uptake in tumours: evidence from biopsy-proven target-negative tumours using 89Zr-immuno-PET von Wijngaarden, Jessica E., Jauw, Yvonne W. S., Zwezerijnen, Gerben J. C., de Wit-van der Veen, Berlinda J., Vugts, Daniëlle J., Zijlstra, Josée M., van Dongen, Guus A. M. S., Boellaard, Ronald, Menke-van der Houven van Oordt, C. Willemien, Huisman, Marc C.

Volltext

Immuno-PET Imaging of Atherosclerotic Plaques with [ 89 Zr]Zr-Anti-CD40 mAb-Proof of Concept von Poels, Kikkie, Schreurs, Maxime, Jansen, Matthijs, Vugts, Danielle J, Seijkens, Tom T P, van Dongen, Guus A M S, Lutgens, Esther, Beaino, Wissam

Volltext

A biparatopic anti‐EGFR nanobody efficiently inhibits solid tumour growth von Roovers, Rob C., Vosjan, Maria J.W.D., Laeremans, Toon, el Khoulati, Rachid, de Bruin, Renée C.G., Ferguson, Kathryn M., Verkleij, Arie J., van Dongen, Guus A.M.S., van Bergen en Henegouwen, Paul M.P.

Volltext

How to obtain the image-derived blood concentration from 89Zr-immuno-PET scans von Wijngaarden, Jessica E., Ahbari, Amina, Pouw, Johanna E. E., Greuter, Henri N. J. M., Bahce, Idris, Zwezerijnen, Gerben J. C., Vugts, Daniëlle J., van Dongen, Guus A. M. S., Boellaard, Ronald, Menke-van der Houven van Oordt, C. Willemien, Huisman, Marc C.

Volltext

A Phase I Dose Escalation Study with Anti-CD44v6 Bivatuzumab Mertansine in Patients with Incurable Squamous Cell Carcinoma of the Head and Neck or Esophagus von TIJINK, Bernard M, BUTER, Jan, DE BREE, Remco, GIACCONE, Giuseppe, LANG, Margreet S, STAAB, Alexander, LEEMANS, C. Rene, VAN DONGEN, Guus A. M. S

Volltext

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging von Perk, Lars R., Vosjan, Maria J. W. D., Visser, Gerard W. M., Budde, Marianne, Jurek, Paul, Kiefer, Garry E., van Dongen, Guus A. M. S.

Volltext

Potential and pitfalls of 89Zr-immuno-PET to assess target status: 89Zr-trastuzumab as an example von Huisman, Marc C., Menke-van der Houven van Oordt, C. Willemien, Zijlstra, Josée M., Hoekstra, Otto S., Boellaard, Ronald, van Dongen, Guus A. M. S., Shah, Dhaval K., Jauw, Yvonne W. S.

Volltext

PET imaging with small-molecule tyrosine kinase inhibitors: TKI-PET von Slobbe, Paul, Poot, Alex J., Windhorst, Albert D., van Dongen, Guus A.M.S.

Volltext

The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors von Pruis, Ilanah J, van Dongen, Guus A M S, Veldhuijzen van Zanten, Sophie E M

Volltext